| Literature DB >> 3304960 |
Abstract
This article reviews the development and pharmacokinetics of a number of new dosage formulations (e.g. transdermal patches and buccal tablets) and new active substances (e.g. isosorbide 5-mononitrate) which have recently been introduced to overcome some of the problems inherent in conventional formulations of organic nitrates.Entities:
Mesh:
Substances:
Year: 1987 PMID: 3304960 DOI: 10.2165/00003495-198700334-00006
Source DB: PubMed Journal: Drugs ISSN: 0012-6667 Impact factor: 9.546